This is the authors' abstract. We don't add key points for this paper.
In well-selected microprolactinoma patients, pituitary surgery performed by an expert neurosurgical team is a valid first-line alternative treatment to dopamine agonists.
No takes yet. Share an insight, caveat, or question.
Baussart et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: